Institutionelle Investoren in Polaryx Therapeutics, Inc. (PLYX)

Neutral Alle meldenden Fondsgesellschaften (SEC-Formular 13F) und deren Investment in dieses Wertpapier über die letzten 4 Quartale. Zusätzlich aktuell von 5 Mutual Funds/ETFs gehalten (N-PORT). Sektor: Gesundheit • Branche: Biotechnologie (Forschung).
Aktien-Detail Fonds-Verzeichnis
Fonds2026/Q22026/Q1
Investment ($)QoQ ($)QoQ (%)Investment ($)QoQ ($)QoQ (%)
5.833.502 $-10.231.966 $
-65,6 %
17.140.152 $
VANGUARD CAPITAL MANAGEMENT LLC4.409.940 $-8.127.473 $
-64,8 %
12.537.413 $
GEODE CAPITAL MANAGEMENT, LLC455.082 $-835.811 $
-64,7 %
1.290.893 $
MILLENNIUM MANAGEMENT LLC964.089 $
VANGUARD FIDUCIARY TRUST CO279.492 $-510.951 $
-64,6 %
790.443 $
STATE STREET CORP154.557 $-284.709 $
-64,8 %
439.266 $
BlackRock, Inc.109.092 $-200.959 $
-64,8 %
310.051 $
HRT FINANCIAL LP218.000 $
NORTHERN TRUST CORP74.445 $-137.137 $
-64,8 %
211.582 $
BANK OF AMERICA CORP /DE/195.660 $
GOLDMAN SACHS GROUP INC101.931 $
UBS Group AG3.413 $-98.488 $
-96,7 %
101.901 $
Squarepoint Ops LLC93.789 $
JANE STREET GROUP, LLC83.633 $
Vanguard Global Advisers, LLC16.806 $-30.958 $
-64,8 %
47.764 $
MORGAN STANLEY41.905 $
Allworth Financial LP20.554 $
Tower Research Capital LLC (TRC)7.985 $-5.480 $
-40,7 %
13.465 $
Fortitude Family Office, LLC503 $
5.833.502 $-10.231.966 $
-65,6 %
17.140.152 $
Erweitert ×